TKIM is a small molecule inhibitor that selectively targets the intermediate (IM) state of the TREK-1 potassium channel (KCNK2). It serves as a valuable research tool for investigating TREK-1s role in pain perception, depression, and neuroprotection in both cellular and animal models.
Molekulargewicht:
371.84
Reinheit:
99.47% (May vary between batches)
CAS Nummer:
[326921-25-9]
Formel:
C18H14ClN3O2S
Target-Kategorie:
Potassium Channel
Anwendungsbeschreibung:
Solubility: DMSO:30 mg/mL (80.68 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten